These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7645428

  • 1. Vitamin D and prostate cancer.
    Feldman D, Skowronski RJ, Peehl DM.
    Adv Exp Med Biol; 1995; 375():53-63. PubMed ID: 7645428
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1993 May; 132(5):1952-60. PubMed ID: 7682937
    [Abstract] [Full Text] [Related]

  • 3. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.
    Schwartz GG, Oeler TA, Uskoković MR, Bahnson RR.
    Anticancer Res; 1994 May; 14(3A):1077-81. PubMed ID: 8074453
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression.
    Krishnan AV, Peehl DM, Feldman D.
    J Cell Biochem; 2003 Feb 01; 88(2):363-71. PubMed ID: 12520538
    [Abstract] [Full Text] [Related]

  • 5. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 01; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 6. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 7. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF, Fitzgerald P, Zou A, Elgort MG, Bischoff ED, Mere L, Mais DE, Bissonnette RP, Heyman RA, Nadzan AM, Reichman M, Allegretto EA.
    Chem Biol; 1999 May 01; 6(5):265-75. PubMed ID: 10322128
    [Abstract] [Full Text] [Related]

  • 8. Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.
    Hedlund TE, Moffatt KA, Uskokovic MR, Miller GJ.
    Clin Cancer Res; 1997 Aug 01; 3(8):1331-8. PubMed ID: 9815816
    [Abstract] [Full Text] [Related]

  • 9. Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer.
    Peehl DM, Krishnan AV, Feldman D.
    J Nutr; 2003 Jul 01; 133(7 Suppl):2461S-2469S. PubMed ID: 12840225
    [Abstract] [Full Text] [Related]

  • 10. Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells.
    Peehl DM, Seto E, Hsu JY, Feldman D.
    J Urol; 2002 Oct 01; 168(4 Pt 1):1583-8. PubMed ID: 12352462
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D and prostate cancer: biologic interactions and clinical potentials.
    Miller GJ.
    Cancer Metastasis Rev; 2002 Oct 01; 17(4):353-60. PubMed ID: 10453279
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
    Swamy N, Chen TC, Peleg S, Dhawan P, Christakos S, Stewart LV, Weigel NL, Mehta RG, Holick MF, Ray R.
    Clin Cancer Res; 2004 Dec 01; 10(23):8018-27. PubMed ID: 15585637
    [Abstract] [Full Text] [Related]

  • 14. Vitamin D and prostate cancer risk: a review of the epidemiological literature.
    Gupta D, Lammersfeld CA, Trukova K, Lis CG.
    Prostate Cancer Prostatic Dis; 2009 Dec 01; 12(3):215-26. PubMed ID: 19350051
    [Abstract] [Full Text] [Related]

  • 15. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.
    Schwartz GG, Wang MH, Zang M, Singh RK, Siegal GP.
    Cancer Epidemiol Biomarkers Prev; 1997 Sep 01; 6(9):727-32. PubMed ID: 9298581
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
    Bauer JA, Thompson TA, Church DR, Ariazi EA, Wilding G.
    Prostate; 2003 May 15; 55(3):159-67. PubMed ID: 12692781
    [Abstract] [Full Text] [Related]

  • 17. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ, Gombart AF, Kwok SH, Park S, Koeffler HP.
    Oncogene; 2000 Oct 19; 19(44):5091-7. PubMed ID: 11042697
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J.
    PLoS Med; 2007 Mar 19; 4(3):e103. PubMed ID: 17388667
    [Abstract] [Full Text] [Related]

  • 20. Characterization of Vitamin D insensitive prostate cancer cells.
    Alagbala AA, Moser MT, Johnson CS, Trump DL, Foster BA.
    J Steroid Biochem Mol Biol; 2007 Mar 19; 103(3-5):712-6. PubMed ID: 17280828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.